Literature DB >> 9120485

Inflammatory neuromuscular disorders associated with chronic lymphoid leukemia: evidence for clonal B cells within muscle and nerve.

A Creange1, I Theodorou, J C Sabourin, C Vital, J P Farcet, R K Gheradi.   

Abstract

It is frequently difficult to determine whether a neuromuscular disorder (NMD) related to a lymphoproliferative disease is neoplastic, paraneoplastic, or incidental. This may explain why neuromuscular complications of chronic lymphoid leukemia (CLL), a frequent disorder, have been rarely reported. We describe 7 patients with CLL and neuromuscular involvement in whom phenotypic and genotypic characterization of infiltrating lymphoid cells was carried out by immunocytochemistry and PCR-amplification of immunoglobulin heavy chain locus. One patient had massive neoplastic infiltration of muscle, and six presented with inflammatory-like NMDs (dermatomyositis: 2, polymyositis: 1, vasculitic mononeuropathy: 2; inflammatory demyelinating neuropathy: 1). Immunocytochemistry on nerve and muscle frozen sections showed a monotypic lymphoid cell population in 3 cases and failed in 4 cases. The PCR analysis of immunoglobulin heavy chain gene (FR3-FR4) rearrangement detected clonal B-cells in all biopsy specimens. There are arguments suggesting that incidental or paraneoplastic inflammatory NMDs may progress to neoplastic infiltration in CLL patients, as a result of the traffic of tumor B-cells from circulation to nerve and muscle tissues. This may question the traditional distinction between inflammatory and neoplastic NMDs in patients with lymphoid cell proliferations.

Entities:  

Mesh:

Year:  1996        PMID: 9120485     DOI: 10.1016/0022-510x(95)00324-u

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Rituximab responsive multiple radiculopathies and cranial nerve palsies in association with chronic lymphocytic leukaemia.

Authors:  Jasper M Morrow; Shirley D'Sa; Rupert A Page; Mahir Al Hilali; Michael P Lunn; Mary M Reilly
Journal:  J Neurol       Date:  2011-09-02       Impact factor: 4.849

2.  A 61-year-old man presented with myopathy, neuropathy, and inflammatory dermatitis responsive to chronic lymphocytic leukemia treatment.

Authors:  Samer Hassan; Muhammad Popalzai; Edward Yu; Monika Wrzolek; Marcel Odaimi
Journal:  Int J Gen Med       Date:  2012-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.